Sucharit Joshi, MD
Nephrology · Portsmouth, NHNPI 1114045184
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,885 of the $5,833 with a category attached, or 83.7%. 6 manufacturers reported payments, led by CSL Behring at 38.6% of the total. 2024 is the largest year on record at $4,375, 3.1 times the $1,410 reported in 2019. Among nephrology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $171.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$2K
- Alnylam Pharmaceuticals Inc.$2K
- Boehringer Ingelheim International GmbH$1K
- Amgen$20
- Calliditas Therapeutics US Inc.$16
- Vifor Pharma, Inc.$12
Across 543 payments — averaging $4013.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$641K
- Boehringer Ingelheim Pharma GmbH & Co.kg$515K
- CSL Behring$349K
- GSK$314K
- Akebia Therapeutics Inc$286K
- Alnylam Pharmaceuticals Inc.$58K
- plus $16K from 3 others
What the payments were for
- Travel & lodging$4,88584%
- Food & beverage$91616%
- Education$321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 12 | $2,249 |
| Alnylam Pharmaceuticals Inc. | 12 | $2,125 |
| Boehringer Ingelheim International GmbH | 7 | $1,410 |
| Amgen | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$1,269
How this compares
$5,833 in reported general payments places this provider in the 90th percentile of 33 nephrology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 39 | $71,005 |
| VelphoroSucroferric Oxyhydroxide | 15 | $49,731 |
| LokelmaSodium Zirconium Cyclosilicate | 19 | $22,386 |
| FarxigaDapagliflozin Propanediol | 16 | $20,734 |
| JardianceEmpagliflozin | 12 | $20,584 |
| Sevelamer Carbonate | 48 | $6,824 |
| Eplerenone | 13 | $2,329 |
| Losartan Potassium | 169 | $2,019 |
| Amlodipine Besylate | 136 | $949 |
| Carvedilol | 58 | $727 |
| Valsartan | 12 | $703 |
| Potassium Chloride | 29 | $668 |
| Spironolactone | 41 | $610 |
| Doxazosin Mesylate | 24 | $463 |
| Metolazone | 11 | $391 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Portsmouth
- Michael DanielskiPortsmouth$142
- Kulli BarrettPortsmouth$122
- Shiv KumarPortsmouth$109
- Satyaki ChakrabartyPortsmouth$77
- Naresh MattaPortsmouth$37
- Ana StankovicSalem$66K
- Elizabeth BrandtLebanon$41K
- John Patrick SiaManchester$12K
- Yishu HanConcord$1K
- Shaikh HoqueNashua$740
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.